Ask Jacki About Health, Stem Cells & Changing Lives


Will Obama’s Stem Cell Announcement Doom Promising Adult Stem Cell Research? — Stem Cell Business Community Suggests Adult Stem Cell Advances Could Be Lost as Embryonic Researchers Compete for Funding

By: PR Newswire | 12 Mar 2009 | 02:06 PM ET
SAN CLEMENTE, Calif., March 12, 2009 /PRNewswire via COMTEX/ — Adult Stem Cell scientists and businesses are concerned that President Obama’s executive order repealing restrictions on Embryonic Stem Cell research will have the unintended consequence of diverting attention and resources away from the promising Adult Stem Cell scientific advances.

STEMTech HealthSciences is a leading company in the field of Stem Cell Nutrition and its chief executive officer is speaking out to create awareness of Adult Stem Cell science’s need for continued support and resources. Adult Stem Cells are naturally created by a person’s own body while Embryonic Stem Cells are extracted from embryos.

“The amazing advances over the past few years in Adult Stem Cell science, including the Nobel Prize winning advances that led to the discovery that Adult Stem Cells travel to tissues and organs needing renewal and become cells of these organs and tissues, are at risk of being eclipsed because of the media and business furor over Embryonic Stem Cells” said STEMTech CEO Ray Carter.

According to Carter, Embryonic Stem Cell research is a multi-billion dollar industry with Wall Street, the media and now the U.S. government joining in to create visibility and mass funding. Meanwhile, the scientific progress made by companies such as STEMTech which owns the rights to the only patented product proven to enhance Adult Stem Cell release in a person’s own body goes relatively unnoticed.

While not a mediagenic billion dollar player however, STEMTech has grown into 8 countries since 2006 with its Stem Cell Nutrition product line which supports healthy Adult Stem Cell physiology.

Christian Drapeau, author of The Stem Cell Theory of Renewal (March 2009, Sutton Hart http://www.suttonhart.com) and pioneer of the Stem Cell Nutrition field, explains the StemEnhance(R) value proposition that “a natural, mild long term increase in the body’s level of circulating Adult Stem Cells delivers substantial wellness benefits”.

According to Christian Drapeau, who serves as STEMTech’s chief science officer, Adult Stem Cells have the greater potential for human wellness and he echoes Carter’s concern that President Obama’s removing restrictions Embryonic Stem Cell research could divert critical resources away from Adult Stem Cell research.

Media Contact: Maggie Jessup maggie@platformstrategy.com SOURCE STEMTech HealthSciences http://www.prnewswire.com Copyright (C) 2009 PR Newswire. All rights reserved -0-

Advertisements

Patients First Act Adult Stem Cells HR 2807 & HR 877

Richard Burt M.D. has completed a study using adult stem cell therapy on patients that has been published in JAMA – The Journal of the American Medical Association. Three of his patients from the study that had received injections of their own adult stem cells, taken from their bone marrow, spoke in front of lawmakers in Washington DC. They are trying to get funding for the same adult stem cell therapy that has helped them. Dr. David Prentice PhD. of the Family Research Council thanked the bi-partisan group that sponsored the bill H.R. 2807 The Patient First Act that would seek funding for the therapies that wil help the patients first. The public should call lawmakers and have support them support the bill.

How can we approve Embryonic Stem Cell legislation? Especially when there is no proof of any true merit and comes with life threatening side effects… then hold out on funding for adult stem cell therapy which has scientific studies proving its effectiveness. The legislation that was introduced above H.R. 2807 was introduced but never made it out of committee.  See below.

H.R. 2807:  Patients First Act of 2007
  Introduced Jun 21, 2007
  Reported by Committee (did not occur)
  Voted on in House (did not occur)
  Voted on in Senate (did not occur)
  Signed by President (did not occur)
This bill never became law. This bill was proposed in a previous session of Congress. Sessions of Congress last two years, and at the end of each session all proposed bills and resolutions that haven’t passed are cleared from the books. Members often reintroduce bills that did not come up for debate under a new number in the next session.

So it was reintroduced on Feb. 4, 2009 as H.R. 877:  Patients First Act of 2009. It was submitted to the House Committee on Energy and Commerce which has 59 members. Here is a link to all the members and all the bills that they are overseeing http://twurl.nl/0mrnuo .

Please join with me and write your representatives and tell them we want H.R. 877  passed. We should have the opportunity to intensify stem cell research which has already been showing evidence of substantial clinical benefit to patients, and for other purposes, and in an ethical manner.  The latest info on the bill is below and I will continue to update it.

H.R. 877:  Patients First Act of 2009

  Introduced Feb 4, 2009
  Referred to Committee View Committee Assignments
  Reported by Committee (pending)
  Voted on in House (pending)
  Voted on in Senate (pending)
  Signed by President (pending)

This bill is in the first step in the legislative process. Introduced bills and resolutions first go to committees that deliberate, investigate, and revise them before they go to general debate. The majority of bills and resolutions never make it out of committee. [Last Updated: Mar 7, 2009 11:31AM]

For more information on stem cell enhancers which aid our bodies in releasing our own adult bone marrow stem cells feel free to visit my website www.stemcellhotline.com. Leave me a comment to let me know what you think of the politics involved with this subject.